Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist.
about
Advances in hormonal therapies for hormone naïve and castration-resistant prostate cancers with or without previous chemotherapyEfficacy and safety of a 3-month dosing regimen of degarelix in Japanese patients with prostate cancer: a phase II maintenance-dose-finding study.Accuracy of serum luteinizing hormone and serum testosterone measurements to assess the efficacy of medical castration in prostate cancer patientsElucidation of the mechanism of suppressed steroidogenesis during androgen deprivation therapy of prostate cancer patients using a mouse model.A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
P2860
Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clinical endocrinological eval ...... antagonist to a LHRH agonist.
@en
type
label
Clinical endocrinological eval ...... antagonist to a LHRH agonist.
@en
prefLabel
Clinical endocrinological eval ...... antagonist to a LHRH agonist.
@en
P2093
P2860
P1476
Clinical endocrinological eval ...... antagonist to a LHRH agonist.
@en
P2093
Haruo Kato
Hidekazu Koike
Hiroshi Matsui
Kazuhiro Suzuki
Kazuto Ito
Masashi Nomura
Seiji Arai
Yasuhiro Shibata
Yoshitaka Sekine
Yoshiyuki Miyazawa
P2860
P2888
P356
10.1186/S12610-015-0023-2
P50
P577
2015-07-03T00:00:00Z